Zobrazeno 1 - 10
of 21
pro vyhledávání: '"Guchelaar HJ"'
Autor:
Marok FZ; Clinical Pharmacy, Saarland University, Saarbruecken, Germany., Wojtyniak JG; Clinical Pharmacy, Saarland University, Saarbruecken, Germany.; Dr. Margarete Fischer-Bosch-Institut of Clinical Pharmacology, Stuttgart, Germany., Selzer D; Clinical Pharmacy, Saarland University, Saarbruecken, Germany., Dallmann R; Division of Biomedical Sciences, Warwick Medical School, University of Warwick, Coventry, UK., Swen JJ; Department of Clinical Pharmacy & Toxicology, Leiden University Medical Center, RC Leiden, The Netherlands., Guchelaar HJ; Department of Clinical Pharmacy & Toxicology, Leiden University Medical Center, RC Leiden, The Netherlands., Schwab M; Dr. Margarete Fischer-Bosch-Institut of Clinical Pharmacology, Stuttgart, Germany.; Departments of Clinical Pharmacology, and of Biochemistry and Pharmacy, University Tuebingen, Tuebingen, Germany.; Cluster of excellence iFIT (EXC2180) 'Image-Guided and Functionally Instructed Tumor Therapies', University Tuebingen, Tuebingen, Germany., Lehr T; Clinical Pharmacy, Saarland University, Saarbruecken, Germany.
Publikováno v:
Clinical pharmacology and therapeutics [Clin Pharmacol Ther] 2024 Jun; Vol. 115 (6), pp. 1282-1292. Date of Electronic Publication: 2024 Jan 24.
Autor:
Knikman JE; Division of Pharmacology, The Netherlands Cancer Institute, Amsterdam, The Netherlands.; Department of Pharmacy & Pharmacology, The Netherlands Cancer Institute, Amsterdam, The Netherlands., Lopez-Yurda M; Biometrics Department, The Netherlands Cancer Institute, Amsterdam, The Netherlands., Meulendijks D; Division of Pharmacology, The Netherlands Cancer Institute, Amsterdam, The Netherlands.; Division of Medical Oncology, Department of Clinical Pharmacology, The Netherlands Cancer Institute, Amsterdam, The Netherlands.; Late Development Oncology, AstraZeneca, Cambridge, UK., Deenen MJ; Department of Clinical Pharmacy, Catharina Hospital, Eindhoven, The Netherlands.; Department of Clinical Pharmacy and Toxicology, Leiden University Medical Centre, Leiden, The Netherlands., Schellens JHM; Department of Pharmaceutical Sciences, Utrecht University, Utrecht, The Netherlands., Beijnen J; Department of Pharmacy & Pharmacology, The Netherlands Cancer Institute, Amsterdam, The Netherlands.; Division of Pharmacoepidemiology and Clinical Pharmacology, Department of Pharmaceutical Sciences, Utrecht University, Utrecht, The Netherlands., Cats A; Division of Medical Oncology, Department of Gastrointestinal Oncology, The Netherlands Cancer Institute, Amsterdam, The Netherlands., Guchelaar HJ; Department of Clinical Pharmacy and Toxicology, Leiden University Medical Centre, Leiden, The Netherlands.
Publikováno v:
Clinical pharmacology and therapeutics [Clin Pharmacol Ther] 2024 Feb; Vol. 115 (2), pp. 269-277. Date of Electronic Publication: 2023 Nov 29.
Autor:
Knikman JE; Division of Pharmacology, The Netherlands Cancer Institute, Amsterdam, the Netherlands.; Department of Pharmacy & Pharmacology, The Netherlands Cancer Institute, Amsterdam, the Netherlands., Wilting TA; Division of Pharmacology, The Netherlands Cancer Institute, Amsterdam, the Netherlands., Lopez-Yurda M; Biometrics Department, The Netherlands Cancer Institute, Amsterdam, the Netherlands., Henricks LM; Department of Clinical Chemistry and Laboratory Medicine, Leiden University Medical Center, Leiden, the Netherlands., Lunenburg CATC; Department of Medical Oncology, Leiden University Medical Center, Leiden, the Netherlands., de Man FM; Department of Medical Oncology, Erasmus MC Cancer Institute, Erasmus University Medical Center, Rotterdam, the Netherlands., Meulendijks D; Division of Pharmacology, The Netherlands Cancer Institute, Amsterdam, the Netherlands.; Department of Clinical Pharmacology, Division of Medical Oncology, The Netherlands Cancer Institute, Amsterdam, the Netherlands.; Late Development Oncology, AstraZeneca, Cambridge, UK., Nieboer P; Department of Internal Medicine, Wilhelmina Hospital Assen, Assen, the Netherlands., Droogendijk HJ; Department of Internal Medicine, Bravis Hospital, Roosendaal, the Netherlands., Creemers GJ; Department of Medical Oncology, Catharina Hospital, Eindhoven, the Netherlands., Mandigers CMPW; Department of Internal Medicine, Canisius-Wilhelmina Hospital, Nijmegen, the Netherlands., Imholz ALT; Department of Internal Medicine, Deventer Hospital, Deventer, the Netherlands., Mathijssen RHJ; Department of Medical Oncology, Erasmus MC Cancer Institute, Erasmus University Medical Center, Rotterdam, the Netherlands., Portielje JEA; Department of Medical Oncology, Leiden University Medical Center, Leiden, the Netherlands.; Department of Medical Oncology, Haga Hospital, The Hague, the Netherlands., Valkenburg-van Iersel L; Department of Internal Medicine, Maastricht University Medical Center, Maastricht, the Netherlands., Vulink A; Department of Medical Oncology, Reinier de Graaf Gasthuis, Delft, the Netherlands., van der Poel MHW; Department of Internal Medicine, Laurentius Hospital, Roermond, the Netherlands., Baars A; Department of Internal Medicine, Hospital Gelderse Vallei, Ede, the Netherlands., Swen JJ; Department of Clinical Pharmacy and Toxicology, Leiden University Medical Center, Leiden, the Netherlands., Gelderblom H; Department of Medical Oncology, Leiden University Medical Center, Leiden, the Netherlands., Schellens JHM; Department of Pharmaceutical Sciences, Utrecht University, Utrecht, the Netherlands., Beijnen JH; Department of Pharmacy & Pharmacology, The Netherlands Cancer Institute, Amsterdam, the Netherlands.; Division of Pharmacoepidemiology and Clinical Pharmacology, Department of Pharmaceutical Sciences, Utrecht University, Utrecht, the Netherlands., Guchelaar HJ; Department of Clinical Pharmacy and Toxicology, Leiden University Medical Center, Leiden, the Netherlands., Cats A; Department of Gastrointestinal Oncology, Division of Medical Oncology, The Netherlands Cancer Institute, Amsterdam, the Netherlands.
Publikováno v:
Journal of clinical oncology : official journal of the American Society of Clinical Oncology [J Clin Oncol] 2023 Dec 10; Vol. 41 (35), pp. 5411-5421. Date of Electronic Publication: 2023 Aug 28.
Autor:
Knikman JE; Division of Pharmacology, The Netherlands Cancer Institute, Plesmanlaan 121, 1066 CX, Amsterdam, the Netherlands., de Vries N, Rosing H, Cats A, Guchelaar HJ, Beijnen JH
Publikováno v:
Die Pharmazie [Pharmazie] 2023 Aug 01; Vol. 78 (8), pp. 107-112.
Autor:
de With M; Department of Medical Oncology, Erasmus Medical Center Cancer Institute, Rotterdam, The Netherlands.; Department of Clinical Chemistry, Erasmus Medical Center, Rotterdam, The Netherlands., Knikman J; Division of Pharmacology, The Netherlands Cancer Institute, Amsterdam, The Netherlands., Schellens JHM; Division of Pharmacoepidemiology and Clinical Pharmacology, Department of Pharmaceutical Sciences, Faculty of Science, Utrecht University, Utrecht, The Netherlands., Gelderblom H; Department of Medical Oncology, Leiden University Medical Center, Leiden, The Netherlands., Cats A; Division of Medical Oncology, Department of Gastrointestinal Oncology, The Netherlands Cancer Institute, Amsterdam, The Netherlands., Guchelaar HJ; Department of Clinical Pharmacy and Toxicology, Leiden University Medical Center, Leiden, The Netherlands.; Leiden Network for Personalised Therapeutics (LNPT), Leiden, The Netherlands., Mathijssen RHJ; Department of Medical Oncology, Erasmus Medical Center Cancer Institute, Rotterdam, The Netherlands., Swen JJ; Department of Clinical Pharmacy and Toxicology, Leiden University Medical Center, Leiden, The Netherlands.; Leiden Network for Personalised Therapeutics (LNPT), Leiden, The Netherlands., Meulendijks D; Division of Pharmacology, The Netherlands Cancer Institute, Amsterdam, The Netherlands.; Division of Medical Oncology, Department of Clinical Pharmacology, The Netherlands Cancer Institute, Amsterdam, The Netherlands.; Late Development Oncology, AstraZeneca, Cambridge, UK.
Publikováno v:
Clinical pharmacology and therapeutics [Clin Pharmacol Ther] 2023 Mar; Vol. 113 (3), pp. 473-475. Date of Electronic Publication: 2022 Nov 09.
Autor:
Lunenburg CATC; Department of Medical Oncology, Leiden University Medical Centre, Leiden, The Netherlands., van der Wouden CH; Department of Clinical Pharmacy & Toxicology, Leiden University Medical Centre, Leiden, The Netherlands., Nijenhuis M; Royal Dutch Pharmacists Association (KNMP), The Hague, The Netherlands. M.Nijenhuis@knmp.nl., Crommentuijn-van Rhenen MH; Royal Dutch Pharmacists Association (KNMP), The Hague, The Netherlands., de Boer-Veger NJ; Pharmacy Boterdiep, Groningen, The Netherlands., Buunk AM; Pharmacy De Katwijkse Apotheek, Katwijk, The Netherlands., Houwink EJF; Department of Public Health and Primary Care (PHEG), Leiden University Medical Center, Leiden, The Netherlands., Mulder H; Department of Clinical Pharmacy, Wilhelmina Hospital, Assen, The Netherlands., Rongen GA; Department of Internal Medicine, Radboud University Medical Centre, Nijmegen, The Netherlands.; Department of Pharmacology and Toxicology, Radboud University Medical Centre, Nijmegen, The Netherlands., van Schaik RHN; Department of Clinical Chemistry, Erasmus University Medical Center, Rotterdam, The Netherlands., van der Weide J; Department of Clinical Chemistry, St. Jansdal Hospital, Harderwijk, The Netherlands., Wilffert B; Groningen Research Institute of Pharmacy, Department of PharmacoTherapy, -Epidemiology and -Economics, University of Groningen, Groningen, The Netherlands.; Department of Clinical Pharmacy and Pharmacology, University of Groningen, University Medical Center Groningen, Groningen, The Netherlands., Deneer VHM; Department of Clinical Pharmacy, University Medical Centre Utrecht, Utrecht, The Netherlands., Swen JJ; Department of Clinical Pharmacy & Toxicology, Leiden University Medical Centre, Leiden, The Netherlands., Guchelaar HJ; Department of Clinical Pharmacy & Toxicology, Leiden University Medical Centre, Leiden, The Netherlands.
Publikováno v:
European journal of human genetics : EJHG [Eur J Hum Genet] 2020 Apr; Vol. 28 (4), pp. 508-517. Date of Electronic Publication: 2019 Nov 19.
Autor:
Lunenburg CATC; Department of Medical Oncology, Leiden University Medical Centre, Leiden, The Netherlands., Henricks LM; Department of Clinical Pharmacology, Division of Medical Oncology, The Netherlands Cancer Institute, Amsterdam, The Netherlands; Division of Pharmacology, The Netherlands Cancer Institute, Amsterdam, The Netherlands., Dreussi E; Experimental and Clinical Pharmacology Unit, National Cancer Institute, Aviano, Italy., Peters FP; Department of Radiotherapy, Leiden University Medical Centre, Leiden, The Netherlands., Fiocco M; Medical Statistics, Department of Biomedical Data Sciences, Leiden University Medical Centre, Leiden, The Netherlands; Mathematical Institute, Leiden University, The Netherlands., Meulendijks D; Dutch Medicines Evaluation Board (CBG-MEB), Utrecht, The Netherlands., Toffoli G; Experimental and Clinical Pharmacology Unit, National Cancer Institute, Aviano, Italy., Guchelaar HJ; Department of Clinical Pharmacy & Toxicology, Leiden University Medical Centre, Leiden, The Netherlands., Swen JJ; Department of Clinical Pharmacy & Toxicology, Leiden University Medical Centre, Leiden, The Netherlands., Cecchin E; Experimental and Clinical Pharmacology Unit, National Cancer Institute, Aviano, Italy., Schellens JHM; Department of Clinical Pharmacology, Division of Medical Oncology, The Netherlands Cancer Institute, Amsterdam, The Netherlands; Division of Pharmacology, The Netherlands Cancer Institute, Amsterdam, The Netherlands; Division of Pharmacoepidemiology & Clinical Pharmacology, Department of Pharmaceutical Sciences, Faculty of Science, Utrecht University, Utrecht, The Netherlands., Gelderblom H; Department of Medical Oncology, Leiden University Medical Centre, Leiden, The Netherlands. Electronic address: A.J.Gelderblom@lumc.nl.
Publikováno v:
European journal of cancer (Oxford, England : 1990) [Eur J Cancer] 2018 Nov; Vol. 104, pp. 210-218. Date of Electronic Publication: 2018 Oct 23.
Autor:
Henricks LM; Division of Pharmacology, The Netherlands Cancer Institute, Amsterdam, Netherlands; Department of Clinical Pharmacology, Division of Medical Oncology, The Netherlands Cancer Institute, Amsterdam, Netherlands., Lunenburg CATC; Department of Medical Oncology, Leiden University Medical Center, Leiden, Netherlands., de Man FM; Department of Medical Oncology, Erasmus MC Cancer Institute, Erasmus University Medical Center, Rotterdam, Netherlands., Meulendijks D; Division of Pharmacology, The Netherlands Cancer Institute, Amsterdam, Netherlands; Department of Clinical Pharmacology, Division of Medical Oncology, The Netherlands Cancer Institute, Amsterdam, Netherlands; Dutch Medicines Evaluation Board (CBG-MEB), Utrecht, Netherlands., Frederix GWJ; Julius Center for Health Sciences and Primary Care, University Medical Center Utrecht, Utrecht, Netherlands., Kienhuis E; Department of Medical Oncology, Erasmus MC Cancer Institute, Erasmus University Medical Center, Rotterdam, Netherlands., Creemers GJ; Department of Medical Oncology, Catharina Hospital, Eindhoven, Netherlands., Baars A; Department of Internal Medicine, Hospital Gelderse Vallei, Ede, Netherlands., Dezentjé VO; Department of Internal Medicine, Reinier de Graaf Hospital, Delft, Netherlands; Division of Medical Oncology, The Netherlands Cancer Institute, Amsterdam, Netherlands., Imholz ALT; Department of Internal Medicine, Deventer Hospital, Deventer, Netherlands., Jeurissen FJF; Department of Internal Medicine, Haaglanden Medical Center, The Hague, Netherlands., Portielje JEA; Department of Medical Oncology, Leiden University Medical Center, Leiden, Netherlands; Department of Internal Medicine, Haga Hospital, The Hague, Netherlands., Jansen RLH; Department of Internal Medicine, Maastricht University Medical Center, Maastricht, Netherlands., Hamberg P; Department of Internal Medicine, Franciscus Gasthuis and Vlietland, Rotterdam, Netherlands., Ten Tije AJ; Department of Internal Medicine, Amphia Hospital, Breda, Netherlands., Droogendijk HJ; Department of Internal Medicine, Bravis Hospital, Roosendaal, Netherlands., Koopman M; Department of Medical Oncology, University Medical Center Utrecht, Utrecht University, Utrecht, Netherlands., Nieboer P; Department of Internal Medicine, Wilhelmina Hospital Assen, Assen, Netherlands., van de Poel MHW; Department of Internal Medicine, Laurentius Hospital, Roermond, Netherlands., Mandigers CMPW; Department of Internal Medicine, Canisius-Wilhelmina Hospital, Nijmegen, Netherlands., Rosing H; Department of Pharmacy and Pharmacology, The Netherlands Cancer Institute, Amsterdam, Netherlands., Beijnen JH; Department of Pharmacy and Pharmacology, The Netherlands Cancer Institute, Amsterdam, Netherlands; Division of Pharmacoepidemiology and Clinical Pharmacology, Department of Pharmaceutical Sciences, Faculty of Science, Utrecht University, Utrecht, Netherlands., Werkhoven EV; Department of Biometrics, The Netherlands Cancer Institute, Amsterdam, Netherlands., van Kuilenburg ABP; Laboratory of Genetic Metabolic Diseases, Department of Clinical Chemistry, Amsterdam UMC, University of Amsterdam, Amsterdam Gastroenterology and Metabolism, Amsterdam, Netherlands., van Schaik RHN; Department of Clinical Chemistry, Erasmus University Medical Center, Rotterdam, Netherlands., Mathijssen RHJ; Department of Medical Oncology, Erasmus MC Cancer Institute, Erasmus University Medical Center, Rotterdam, Netherlands., Swen JJ; Department of Clinical Pharmacy and Toxicology, Leiden University Medical Center, Leiden, Netherlands., Gelderblom H; Department of Medical Oncology, Leiden University Medical Center, Leiden, Netherlands., Cats A; Department of Gastrointestinal Oncology, Division of Medical Oncology, The Netherlands Cancer Institute, Amsterdam, Netherlands., Guchelaar HJ; Department of Clinical Pharmacy and Toxicology, Leiden University Medical Center, Leiden, Netherlands., Schellens JHM; Division of Pharmacology, The Netherlands Cancer Institute, Amsterdam, Netherlands; Department of Clinical Pharmacology, Division of Medical Oncology, The Netherlands Cancer Institute, Amsterdam, Netherlands; Division of Pharmacoepidemiology and Clinical Pharmacology, Department of Pharmaceutical Sciences, Faculty of Science, Utrecht University, Utrecht, Netherlands. Electronic address: j.schellens@gmail.com.
Publikováno v:
The Lancet. Oncology [Lancet Oncol] 2018 Nov; Vol. 19 (11), pp. 1459-1467. Date of Electronic Publication: 2018 Oct 19.
Autor:
Lunenburg C; Department of Medical Oncology, Leiden University Medical Center, P.O. Box 9600, Post zone C7-P, 2300 RC, Leiden, The Netherlands., Swen JJ; Department of Clinical Pharmacy and Toxicology, Leiden University Medical Center, Leiden, The Netherlands., Guchelaar HJ; Department of Clinical Pharmacy and Toxicology, Leiden University Medical Center, Leiden, The Netherlands., Gelderblom H; Department of Medical Oncology, Leiden University Medical Center, P.O. Box 9600, Post zone C7-P, 2300 RC, Leiden, The Netherlands. A.J.Gelderblom@lumc.nl.
Publikováno v:
Journal of gastrointestinal cancer [J Gastrointest Cancer] 2017 Mar; Vol. 48 (1), pp. 117-118.
Autor:
Lunenburg CA; Department of Medical Oncology, Leiden University Medical Center, Leiden, The Netherlands., van Staveren MC; Department of Pharmacy, Treant Healthgroup, The Netherlands.; Department of Clinical Pharmacy & Toxicology, Leiden University Medical Center, Leiden, The Netherlands., Gelderblom H; Department of Medical Oncology, Leiden University Medical Center, Leiden, The Netherlands., Guchelaar HJ; Department of Clinical Pharmacy & Toxicology, Leiden University Medical Center, Leiden, The Netherlands., Swen JJ; Department of Clinical Pharmacy & Toxicology, Leiden University Medical Center, Leiden, The Netherlands.
Publikováno v:
Pharmacogenomics [Pharmacogenomics] 2016 May; Vol. 17 (7), pp. 721-9. Date of Electronic Publication: 2016 May 16.